EMT
FAM3C
biomarker
cancer
therapeutic target
Journal
Biomarkers in medicine
ISSN: 1752-0371
Titre abrégé: Biomark Med
Pays: England
ID NLM: 101312535
Informations de publication
Date de publication:
04 2021
04 2021
Historique:
pubmed:
6
3
2021
medline:
27
1
2022
entrez:
5
3
2021
Statut:
ppublish
Résumé
FAM3C is a member of the FAM3 family. Recently, overexpression of FAM3C has been reported in numerous types of cancer, including breast and colon cancer. Increasing evidence suggests that elevated FAM3C and its altered subcellular localization are closely associated with tumor formation, invasion, metastasis and poor survival. Moreover, FAM3C has been found to be the regulator of various proteins that associate with cancer, including Ras, STAT3, TGF-β and LIFR. This review summarizes the current knowledge regarding FAM3C, including its structure, expression patterns, regulation, physiological roles and regulatory functions in various malignancies. These findings highlight the importance of FAM3C in cancer development and provide evidence that FAM3C is a novel biomarker and potential therapeutic target for various cancers.
Identifiants
pubmed: 33666514
doi: 10.2217/bmm-2020-0179
doi:
Substances chimiques
Biomarkers, Tumor
0
Cytokines
0
FAM3C protein, human
0
Neoplasm Proteins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM